tiprankstipranks
Advertisement
Advertisement

ACIU Stock Latest News

AC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program
Company AnnouncementsAC Immune Unveils 12-Month Interim Data from ACI-24 Alzheimer’s Trial and Expands Takeda-Backed Program
10d ago
6K
ACIU
AC Immune announces interim data from first three cohorts of ABATE trial
PremiumThe Fly
AC Immune announces interim data from first three cohorts of ABATE trial
10d ago
ACIU
AC Immune Shareholders Back Capital Band, Governance Slate and Pay Caps at June 11 AGM
PremiumCompany Announcements
AC Immune Shareholders Back Capital Band, Governance Slate and Pay Caps at June 11 AGM
28d ago
6K
ACIU
AC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial
PremiumCompany Announcements
AC Immune Secures $4 Million Goradia Foundation Grant to Extend Phase 2 Parkinson’s Trial
29d ago
6K
ACIU
AC Immune presents new Phase 1 data on uptake of ACI-19626
PremiumThe Fly
AC Immune presents new Phase 1 data on uptake of ACI-19626
2M ago
ACIU
AC Immune Sets June AGM and Reshapes Leadership as Long-Serving CEO Retires
PremiumCompany AnnouncementsAC Immune Sets June AGM and Reshapes Leadership as Long-Serving CEO Retires
2M ago
6K
ACIU
AC Immune CEO and Co-Founder Andrea Pfeifer to Retire at June 11 AGM; Board Chair Martin Zügel Named Interim Chief
Premium
Company Announcements
AC Immune CEO and Co-Founder Andrea Pfeifer to Retire at June 11 AGM; Board Chair Martin Zügel Named Interim Chief
2M ago
6K
ACIU
AC Immune reports Q1 EPS (15c), consensus (14c)
Premium
The Fly
AC Immune reports Q1 EPS (15c), consensus (14c)
2M ago
ACIU
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
PremiumCompany Announcements
AC Immune Triggers $12 Million Takeda Milestone as Final ABATE Cohort Starts in Alzheimer’s Trial
2M ago
6K
ACIU
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
PremiumCompany Announcements
AC Immune Posts Q1 2026 Update, Extends Cash Runway and Advances Neurodegeneration Pipeline
2M ago
6K
ACIU
Is ACIU a Buy, Before Earnings?
PremiumPre-Earnings
Is ACIU a Buy, Before Earnings?
3M ago
ACIU
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
PremiumThe Fly
Leerink calls AC Immune- Eli Lilly Tau amendment ‘great news’
3M ago
LLY
ACIU
AC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
PremiumCompany AnnouncementsAC Immune Secures Amended Tau Drug Collaboration with Lilly, Adds CHF 10 Million Upfront
3M ago
6K
ACIU
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
Premium
The Fly
AC Immune announces amendment to Eli Lilly license pact, to receive CHF 10M
3M ago
LLY
ACIU
AC Immune’s PET tracer shows efficacy detecting brain pathologies
Premium
The Fly
AC Immune’s PET tracer shows efficacy detecting brain pathologies
4M ago
ACIU
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
PremiumRatings
AC Immune: Advancing Neurology Pipeline and Imminent Alzheimer’s Vaccine Data Support Buy Rating
4M ago
ACIU
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
PremiumRatings
AC Immune: Advancing Alzheimer’s and Parkinson’s Pipeline Catalysts Underpin Buy Rating and Favorable Risk‑Reward
4M ago
ACIU
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
PremiumCompany Announcements
AC Immune Posts 2025 Results, Sharpens Pipeline Focus and Extends Cash Runway to 2027
4M ago
6K
ACIU
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
PremiumThe Fly
AC Immune reports FY25 EPS (CHF 0.70) vs (CHF 0.51) last year
4M ago
ACIU
ACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
PremiumPre-EarningsACIU Earnings Report this Week: Is It a Buy, Ahead of Earnings?
4M ago
ACIU
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
Premium
Company Announcements
AC Immune Doses First Participant in Phase 1 Trial of NLRP3 Inhibitor ACI-19764
5M ago
6K
ACIU
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
Premium
The Fly
AC Immune initiates Phase 1 trial of NLRP3 inhibitor
5M ago
ACIU

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >